REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio Neo Farmaco del Ecuador Neofarmaco CIA Ltda (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Laboratorio Neo Farmaco del Ecuador Neofarmaco CIA Ltda Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Laboratorio Neo Farmaco del Ecuador Neofarmaco CIA Ltda is a company in Ecuador, with a head office in Ambato. It operates in the Pharmaceutical and Medicine Manufacturing industry. Laboratorio Neo Farmaco del Ecuador Neofarmaco CIA Ltda was incorporated on March 11, 2010. 67 (2021) employees currently work for Laboratorio Neo Farmaco del Ecuador Neofarmaco CIA Ltda. In 2022, the company reported a net sales revenue increase of 11.71%. Its’ total assets recorded a growth of 4.3%. The net profit margin of Laboratorio Neo Farmaco del Ecuador Neofarmaco CIA Ltda decreased by 1.16% in 2022.

Headquarters
Av.Atahualpa Km. 3
Ambato; Tungurahua;

Contact Details: Purchase the Laboratorio Neo Farmaco del Ecuador Neofarmaco CIA Ltda report to view the information.

Website: http://www.neofarmaco.com

Basic Information
Total Employees:
Purchase the Laboratorio Neo Farmaco del Ecuador Neofarmaco CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Laboratorio Neo Farmaco del Ecuador Neofarmaco CIA Ltda report to view the information.
Registered Capital:
Purchase the Laboratorio Neo Farmaco del Ecuador Neofarmaco CIA Ltda report to view the information.
Incorporation Date:
March 11, 2010
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
43.09%
Purchase this report to view the information.
18.97%
Purchase this report to view the information.
18.97%
Purchase this report to view the information.
18.97%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Laboratorio Neo Farmaco del Ecuador Neofarmaco CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
11.71%
Total operating revenue
11.51%
Operating profit (EBIT)
-49.11%
EBITDA
-26.93%
Net Profit (Loss) for the Period
-16.42%
Total assets
4.3%
Total equity
1.82%
Operating Profit Margin (ROS)
-4.16%
Net Profit Margin
-1.16%
Return on Equity (ROE)
-0.97%
Debt to Equity Ratio
-0.16%
Quick Ratio
-2.62%
Cash Ratio
-2.23%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?